Lesinurad/Allopurinol 200/300 FDC Tablets Bioequivalence

Trial Identifier: RDEA594-503
Sponsor: Ardea Biosciences, Inc.
NCTID:: NCT02888054
Start Date: August 2016
Primary Completion Date: October 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation

Trial Locations

Country Location
USA, TX Austin, TX, USA, 78744